Kisqali 600 MG daily dose 63S
Ended Awarded
- Contract number
- SPE2DB25FE1EA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,532
Award facts
- Contract value 100% obligated
- $17,531.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $17,531.71 firm fixed-price delivery order to AmerisourceBergen Drug Corp for KISQALI 600 mg daily dose in a 63-tablet supply. The order was competitively awarded without set-aside designation and has an ultimate completion date of September 26, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems. KISQALI (ribociclib) is a prescription cancer medication used in breast cancer treatment, reflecting the company's role in supplying specialized pharmaceuticals to the Defense Health Agency and other government healthcare systems. The company's contract history demonstrates consistent capability in fulfilling federal medical supply needs through open competition, with delivery orders ranging from small-value transactions to substantial orders exceeding $45,000, showcasing its versatility across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FE1EA?
SPE2DB25FE1EA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FE1EA worth?
The government has obligated $17,532 on SPE2DB25FE1EA.
Is contract SPE2DB25FE1EA an order under another contract?
Yes. SPE2DB25FE1EA is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FE1EA competed?
The extent of competition for SPE2DB25FE1EA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award